Pharmacotherapy of Asthma: Age-Related Considerations
Presented by Stanley Szefler, M.D.
March 13, 2013
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites you to participate in a webinar dedicated to the topic of Pharmacotherapy of Asthma.
A lecture entitled “Pharmacotherapy of Asthma: Age-related Considerations” will be presented via Webinar by Stanley Szefler, M.D., Director of the Weinberg Clinical Research Unit/Pediatrics Section at National Jewish Health in Denver, Colorado and Professor of Pediatrics and Pharmacology at the University of Colorado Denver School of Medicine, on Wednesday, March 13, 2013 at 12:00 p.m. Eastern Time. This lecture will discuss the core medications used in the treatment of asthma that will include bronchodilators, anti-inflammatory medications and immunomodulators. There will also be a discussion of new medications that are currently being evaluated.
A major consideration in developing medications for the treatment of asthma is the age-related differences in disease presentation and feasibility of medication delivery. Treatment selection will therefore be placed in the context of age. The subject matter may be of particular interest to general pediatricians.
This presentation is part of the Principles of Pediatric Clinical Pharmacology lecture series which addresses the fundamentals of clinical pharmacology from a pediatric perspective. Weekly lectures are given via Webinar in a variety of topics, including drug metabolism and transport, assessment of drug effects, pharmacotherapy, and pediatric drug formulations. To register for this lecture, go to the course Web site and click the Register button on the main navigation bar. Enter your name and e-mail and click next. Be sure to select the March 13 lecture from the course listing.
Please contact email@example.com if you have any questions.
2D Vaccine Barcoding Pilot Educational Forum
April 14-15, 2013
New Orleans, LA
This forum is part of a pilot project initiated by the CDC in response to the Food and Drug Administration (FDA) recently released final "Guidance for Industry: Bar Code Label Requirements - Questions and Answers" and a study on the impact of 2D barcoded vaccines. A major portion of the project is a pilot implementation involving 10 CDC immunization program grantees, over 200 immunizing provider sites, and 2 vaccine manufacturers.
You can also view the invitation and learn more about vaccine barcoding at: http://www2.aap.org/immunization/pediatricians/barcoding.html#EdForum
The Pediatrician and Substance Use: Practical strategies to minimize the impact of tobacco, alcohol and other
children, teens and young adults
April 26 - 28, 2013
As a pediatrician or primary care provider for children, adolescents and their families, you are
faced with both patients and family
members who use tobacco, alcohol and other drugs (TAOD). Substance use in the home affects the entire family—parents, children
siblings—and primary care providers are in an ideal position to detect and
intervene when necessary.
This two and a half day conference will bring together experts in the fields of general pediatrics, adolescent medicine, developmental medicine and addiction to discuss the developmental, behavioral and medical aspects of the problem and to provide a comprehensive approach to addressing substance abuse in the primary care setting. Major topics covered will include tobacco use, drug-endangered children, risk and protective factors for adolescent substance use, interviewing adolescents, screening, brief intervention and referral to treatment (SBIRT), parent guidance, opioid misuse and important new information about the adolescent brain and its special
susceptibility to the effects of TAOD. Special sessions will focus on cannabinoid physiology and marijuana policy, treatment for opioid dependence and “new” psychoactive
drugs used by teens and youth.
For more information, visit: http://www.aap.org/substanceuse2013.